3

ANTHONY DAILLEY

Company: NovaBay Pharmaceuticals, Inc.
Filed: October 24, 2007
Period of Report: October 24, 2007
Accession Number: 0001181431-07-063467

View Document ↗ View on SEC.gov ↗